EUVIMEDEUVIMED entdecken
Crossref

Primary melanoma stage as a predictor of survival in advanced disease: Findings from the Spanish Melanoma Registry GEM1801

Maria Gonzalez-Cao, Susana Puig, José Luis Manzano, Miguel-Ángel Berciano-Guerrero, Ainara Soria, Lourdes Gutiérrez Sanz, Pablo Cerezuela-Fuentes, Guillermo Crespo, Eva Muñoz-Couselo, Teresa Puértolas, Carlos Aguado de la Rosa, Luis Antonio Fernández und 8 weitere

Journal of the American Academy of Dermatology · 2026-10

DOI: 10.1016/j.jaad.2026.09.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Maria Gonzalez-Cao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain. Electronic address: mgonzalezcao@oncorosel…. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Systemic relapse after stage I melanoma is uncommon, but accounts for nearly one-third of metastatic melanoma cases. The prognostic impact of primary melanoma stage in advanced disease is unknown. METHODS: Overall survival was analyzed in patients with advanced melanoma from the Spanish Melanoma Registry (2018-2024), stratified by primary stage. RESULTS: Among 365 patients with metastatic melanoma treated at first line, 58 had prior stage I, 32 IIA, 80 IIB/C, and 195 III. Median time to relapse was 52 months for stage I, 30 months in IIA, 27 months in IIB/C and 25 months in stage III (P = .0001). At systemic relapse, patients with previous stage I more frequently had ≥3 metastatic sites (odds ratio [OR], 1.89; 95% confidence interval [CI], 1.06-3.35), brain metastases (OR, 4.02; 95% CI, 2.13-7.58), and elevated lactate dehydrogenase (OR 2.19, 95% CI, 1.18-4.04). Median overall survival was shorter for patients with prior stage I (19.8 m, 95% CI, 12-55.9) versus stage IIA (60.1 m, 95% CI, 52.8-not reached), IIB/C (32.6 m, 95% CI, 18.9-not reached), and III (43 m, 95% CI, 25.5-62.3) (P = .024). CONCLUSIONS: Systemic relapse after stage I melanoma is associated with higher tumor burden and poorer survival than relapse after stage II/III.

Schlagwörter

Stichwörter der Autor:innen

melanomaprognosisreal world datastage I

Autor:innen und Institutionen

  • Medical Oncology Department, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain. Electronic address: mgonzalezcao@oncorosell.com.
  • Dermatology Department, Hospital Clinic, Barcelona, Spain.
  • Medical Oncology Department, Institut Català d'Oncologia, ICO-Badalona, H. Germans Trias i Pujol, Badalona, Spain.
  • Medical Oncology Department, Hospital Regional Universitario (HRU), Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Málaga, Spain.
  • Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Zitieren

APA

Gonzalez-Cao, M., Puig, S., Manzano, J. L., Berciano-Guerrero, M. Á., Soria, A., Sanz, L. G., Cerezuela-Fuentes, P., Crespo, G., Muñoz-Couselo, E., Puértolas, T., Aguado de la Rosa, C., Fernández, L. A., Espinosa, E., Bellido, L., Castro, R. L., Cunquero-Tomás, A., Ayala de Miguel, P., Martín Algarra, S., Márquez-Rodas, I., & Spanish Melanoma Group (2026). Primary melanoma stage as a predictor of survival in advanced disease: Findings from the Spanish Melanoma Registry GEM1801. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.112

Vancouver

Gonzalez-Cao M, Puig S, Manzano JL, Berciano-Guerrero MÁ, Soria A, Sanz LG, et al. Primary melanoma stage as a predictor of survival in advanced disease: Findings from the Spanish Melanoma Registry GEM1801. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.112

BibTeX
@article{GonzalezCao2026,
  author = {Gonzalez-Cao, Maria and Puig, Susana and Manzano, José Luis and Berciano-Guerrero, Miguel-Ángel and Soria, Ainara and Sanz, Lourdes Gutiérrez and Cerezuela-Fuentes, Pablo and Crespo, Guillermo and Muñoz-Couselo, Eva and Puértolas, Teresa and Aguado de la Rosa, Carlos and Fernández, Luis Antonio and Espinosa, Enrique and Bellido, Lorena and Castro, Rafael López and Cunquero-Tomás, Alberto and Ayala de Miguel, Pablo and Martín Algarra, Salvador and Márquez-Rodas, Iván and Spanish Melanoma Group, Spanish Melanoma Group},
  title = {Primary melanoma stage as a predictor of survival in advanced disease: Findings from the Spanish Melanoma Registry GEM1801},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.09.112}
}
Kostenlos starten →